The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Neurostimulation for Parkinson's Disease with Early Motor Complications
Open accessAbstract
BACKGROUND: Subthalamic stimulation reduces motor disability and improves quality of life in patients with advanced Parkinson's disease who have severe levodopa-induced motor complications. We hypothesized that neurostimulation would be beneficial at an earlier stage of Parkinson's disease. METHODS: In this 2-year trial, we randomly assigned 251 patients with Parkinson's disease and early motor complications (mean age, 52 years; mean duration of disease, 7.5 years) to undergo neurostimulation plus medical therapy or medical therapy alone. The primary end point was quality of life, as assessed with the use of the Parkinson's Disease Questionnaire (PDQ-39) summary index (with scores ranging from 0 to 100 and higher scores indicating worse function). Major secondary outcomes included parkinsonian motor disability, activities of daily living, levodopa-induced motor complications (as assessed with the use of the Unified Parkinson's Disease Rating Scale, parts III, II, and IV, respectively), and time with good mobility and no dyskinesia. RESULTS: For the primary outcome of quality of life, the mean score for the neurostimulation group improved by 7.8 points, and that for the medical-therapy group worsened by 0.2 points (between-group difference in mean change from baseline to 2 years, 8.0 points; P=0.002). Neurostimulation was superior to medical therapy with respect to motor disability (P<0.001), activities of daily living (P<0.001), levodopa-induced motor complications (P<0.001), and time with good mobility and no dyskinesia (P=0.01). Serious adverse events occurred in 54.8% of the patients in the neurostimulation group and in 44.1% of those in the medical-therapy group. Serious adverse events related to surgical implantation or the neurostimulation device occurred in 17.7% of patients. An expert panel confirmed that medical therapy was consistent with practice guidelines for 96.8% of the patients in the neurostimulation group and for 94.5% of those in the medical-therapy group. CONCLUSIONS: Subthalamic stimulation was superior to medical therapy in patients with Parkinson's disease and early motor complications. (Funded by the German Ministry of Research and others; EARLYSTIM ClinicalTrials.gov number, NCT00354133.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
A sharper Bonferroni procedure for multiple tests of significance
HOCHBERG, Y. (1988) · Biometrika · doi:10.1093/biomet/75.4.800 · Cited by 4,829
Systematic review of levodopa dose equivalency reporting in Parkinson's disease
Tomlinson, C. L., Stowe, R., Patel, S., Rick, C., Gray, R., & Clarke, C. E. (2010) · Movement Disorders · doi:10.1002/mds.23429 · Cited by 4,219
Unified Parkinson's Disease Rating Scale
(2012) · SpringerReference · doi:10.1007/springerreference_184495 · Cited by 3,066
A Randomized Trial of Deep-Brain Stimulation for Parkinson's Disease
Deuschl, G., Schade-Brittinger, C., Krack, P., Volkmann, J., Schäfer, H., Bötzel, K., Daniels, C., Deutschländer, A., Dillmann, U., Eisner, W., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060281 · Cited by 2,944
Self-citationKrack, P., Batir, A., Van Blercom, N., Chabardes, S., Fraix, V., Ardouin, C., Koudsie, A., Limousin, P. D., Benazzouz, A., LeBas, J. F., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035275 · Cited by 2,249
Self-citationElectrical Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease
Limousin, P., Krack, P., Pollak, P., Benazzouz, A., Ardouin, C., Hoffmann, D., & Benabid, A.-L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810153391603 · Cited by 1,853
Self-citationRevising axis V for DSM-IV: a review of measures of social functioning
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.9.1148 · Cited by 1,407
Pallidal versus Subthalamic Deep-Brain Stimulation for Parkinson's Disease
Follett, K. A., Weaver, F. M., Stern, M., Hur, K., Harris, C. L., Luo, P., Marks, W. J., Rothlind, J., Sagher, O., Moy, C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907083 · Cited by 1,355
Reliability, validity, and clinical correlates of apathy in Parkinson's disease
(1992) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.4.2.134 · Cited by 1,185
Seppi, K., Weintraub, D., Coelho, M., Perez‐Lloret, S., Fox, S. H., Katzenschlager, R., Hametner, E., Poewe, W., Rascol, O., Goetz, C. G., et al. (2011) · Movement Disorders · doi:10.1002/mds.23884 · Cited by 1,141
Subthalamic nucleus deep brain stimulation: Summary and meta-analysis of outcomes
Kleiner-Fisman, G., Herzog, J., Fisman, D. N., Tamma, F., Lyons, K. E., Pahwa, R., Lang, A. E., & Deuschl, G. (2006) · Movement Disorders · doi:10.1002/mds.20962 · Cited by 957
Self-citationWilliams, A., Gill, S., Varma, T., Jenkinson, C., Quinn, N., Mitchell, R., Scott, R., Ives, N., Rick, C., Daniels, J., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70093-4 · Cited by 733
Fox, S. H., Katzenschlager, R., Lim, S., Ravina, B., Seppi, K., Coelho, M., Poewe, W., Rascol, O., Goetz, C. G., & Sampaio, C. (2011) · Movement Disorders · doi:10.1002/mds.23829 · Cited by 523
A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease
Voon, V., Krack, P., Lang, A. E., Lozano, A. M., Dujardin, K., Schüpbach, M., D’Ambrosia, J., Thobois, S., Tamma, F., Herzog, J., et al. (2008) · Brain · doi:10.1093/brain/awn214 · Cited by 472
Self-citationMoro, E., Lozano, A. M., Pollak, P., Agid, Y., Rehncrona, S., Volkmann, J., Kulisevsky, J., Obeso, J. A., Albanese, A., Hariz, M. I., et al. (2010) · Movement Disorders · doi:10.1002/mds.22735 · Cited by 468
Self-citationMotor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants
Fasano, A., Romito, L. M., Daniele, A., Piano, C., Zinno, M., Bentivoglio, A. R., & Albanese, A. (2010) · Brain · doi:10.1093/brain/awq221 · Cited by 429
Okun, M. S., Gallo, B. V., Mandybur, G., Jagid, J., Foote, K. D., Revilla, F. J., Alterman, R., Jankovic, J., Simpson, R., Junn, F., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70308-8 · Cited by 409
ACCOUNTING FOR DROPOUT BIAS USING MIXED-EFFECTS MODELS
Mallinckrodt, C. H., Clark, W. S., & David, S. R. (2001) · Journal of Biopharmaceutical Statistics · doi:10.1081/bip-100104194 · Cited by 398
Health‐related quality‐of‐life scales in Parkinson's disease: Critique and recommendations
Martinez‐Martin, P., Jeukens‐Visser, M., Lyons, K. E., Rodriguez‐Blazquez, C., Selai, C., Siderowf, A., Welsh, M., Poewe, W., Rascol, O., Sampaio, C., et al. (2011) · Movement Disorders · doi:10.1002/mds.23834 · Cited by 308
Horstink, M., Tolosa, E., Bonuccelli, U., Deuschl, G., Friedman, A., Kanovsky, P., Larsen, J. P., Lees, A., Oertel, W., Poewe, W., et al. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01547.x · Cited by 297
Self-citationGOLDMAN, M. J. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.8.1119-a · Cited by 282
Post, B., Merkus, M. P., de Bie, R. M. A., de Haan, R. J., & Speelman, J. D. (2005) · Movement Disorders · doi:10.1002/mds.20640 · Cited by 266
Self-citationNeurosurgery at an earlier stage of Parkinson disease: A randomized, controlled trial
Schüpbach, W. M. M., Maltête, D., Houeto, J. L., du Montcel, S. T., Mallet, L., Welter, M. L., Gargiulo, M., Béhar, C., Bonnet, A. M., Czernecki, V., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000250253.03919.fb · Cited by 244
Self-citationDetermining minimally important differences for the PDQ-39 Parkinson's disease questionnaire
Peto, V. (2001) · Age and Ageing · doi:10.1093/ageing/30.4.299 · Cited by 227
Predictors of cognitive and psychosocial outcome after STN DBS in Parkinson's Disease
Smeding, H. M. M., Speelman, J. D., Huizenga, H. M., Schuurman, P. R., & Schmand, B. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.140012 · Cited by 194
Horstink, M., Tolosa, E., Bonuccelli, U., Deuschl, G., Friedman, A., Kanovsky, P., Larsen, J. P., Lees, A., Oertel, W., Poewe, W., et al. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01548.x · Cited by 173
Self-citationBeunckens, C., Molenberghs, G., & Kenward, M. G. (2005) · Clinical Trials · doi:10.1191/1740774505cn119oa · Cited by 154
Deuschl, G., Schüpbach, M. W. M., Knudsen, K., Pinsker, M. O., Cornu, P., Rau, J., Agid, Y., & Schade‐Brittinger, C. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.07.004 · Cited by 126
Self-citationInter- and Intra-Rater Reliability of the Brief Psychiatric Rating Scale
Flemenbaum, A., & Zimmermann, R. L. (1973) · Psychological Reports · doi:10.2466/pr0.1973.33.3.783 · Cited by 123
A short psychosocial questionnaire for patients with Parkinson's disease
Marinus, J., Jeukens‐Visser, M., Martínez-Martín, P., van Hilten, J. J., & Stiggelbout, A. M. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00569-3 · Cited by 106
Post, B., Muslimović, D., van Geloven, N., Speelman, J. D., Schmand, B. A., de Haan, R. J., & on behalf of the CARPA‐study group (2011) · Movement Disorders · doi:10.1002/mds.23467 · Cited by 102
Self-citationHealth‐related quality of life in parkinson's disease: A study of outpatient clinic attenders
Fitzpatrick, R. M., Peto, V., Jenkinson, C., Greenhall, R., & Hyman, N. M. (1997) · Movement Disorders · doi:10.1002/mds.870120613 · Cited by 98
Daniels, C., Krack, P., Volkmann, J., Raethjen, J., Pinsker, M. O., Kloß, M., Tronnier, V. M., Schnitzler, A., Wojtecki, L., Bötzel, K., et al. (2011) · Movement Disorders · doi:10.1002/mds.23907 · Cited by 93
Self-citationComparative responsiveness of Parkinson's disease scales to change over time
Schrag, A. E., Spottke, A. E., Quinn, N. P., & Dodel, R. C. (2009) · Movement Disorders · doi:10.1002/mds.22438 · Cited by 71
(2000) · doi:10.1002/1531-8257(200011)15:6<1112::aid-mds1008>3.0.co;2-a
Cited by
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
Balestrino, R., & Schapira, A. H. V. (2020) · European Journal of Neurology · doi:10.1111/ene.14108 · Cited by 1,508
Pharmacological Treatment of Parkinson Disease: A Review
Connolly, B. S., & Lang, A. E. (2014) · JAMA · doi:10.1001/jama.2014.3654 · Cited by 1,498
Deep brain stimulation: current challenges and future directions
Lozano, A. M., Lipsman, N., Bergman, H., Brown, P., Chabardes, S., Chang, J. W., Matthews, K., McIntyre, C. C., Schlaepfer, T. E., Schulder, M., et al. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-018-0128-2 · Cited by 1,450
Self-citationParkinson disease-associated cognitive impairment
Aarsland, D., Batzu, L., Halliday, G. M., Geurtsen, G. J., Ballard, C., Ray Chaudhuri, K., & Weintraub, D. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00280-3 · Cited by 1,371
Metadata
- Authors
- Schuepbach, W. M. M., Rau, J., Knudsen, K., Volkmann, J., Krack, P., Timmermann, L., Hälbig, T. D., Hesekamp, H., Navarro, S. M., Meier, N., Falk, D., Mehdorn, M., Paschen, S., Maarouf, M., Barbe, M. T., Fink, G. R., Kupsch, A., Gruber, D., Schneider, G.-H., Seigneuret, E., Kistner, A., Chaynes, P., Ory-Magne, F., Brefel Courbon, C., Vesper, J., Schnitzler, A., Wojtecki, L., Houeto, J.-L., Bataille, B., Maltête, D., Damier, P., Raoul, S., Sixel-Doering, F., Hellwig, D., Gharabaghi, A., Krüger, R., Pinsker, M. O., Amtage, F., Régis, J.-M., Witjas, T., Thobois, S., Mertens, P., Kloss, M., Hartmann, A., Oertel, W. H., Post, B., Speelman, H., Agid, Y., Schade-Brittinger, C., & Deuschl, G.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-02-14
- Volume
- 368
- Issue
- 7
- Pages
- 610-622
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2106956384
- Cited by
- 1,430
- References
- 38
- FWCI
- 73.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.